Literature DB >> 703928

General disease in 120 necropsy-proven cases of multiple sclerosis.

I V Allen, J H Millar, M J Hutchinson.   

Abstract

The general pathology in 120 necropsy-proven cases of multiple sclerosis has been compared with that of matched neurological and general controls. There was no significant difference in the incidence of coronary thrombosis, myocardial infarction, cerebral haemorrhage, thyroid atrophy and splenic haemosiderosis. There was also no significant difference in malignancy in the three groups. The implications of these findings with particular reference to immunopathology are discussed. 74% of patients with multiple sclerosis died from complications of the disease; 26% died from apparently unrelated diseases.

Entities:  

Mesh:

Year:  1978        PMID: 703928     DOI: 10.1111/j.1365-2990.1978.tb00546.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  5 in total

1.  Perivascular iron deposition and other vascular damage in multiple sclerosis.

Authors:  C W Adams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

2.  Multiple sclerosis and motor neurone disease: survival and how certified after death.

Authors:  F O'Malley; G Dean; M Elian
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

3.  The development of primary central nervous system B-cell lymphoma in multiple sclerosis.

Authors:  Mark K Lyons; Orland K Boucher; Barry D Birch; Naresh P Patel
Journal:  Neurohospitalist       Date:  2011-07

4.  Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.

Authors:  J G Phadke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

5.  Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry.

Authors:  N Koch-Henriksen; H Brønnum-Hansen; E Stenager
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.